Scientists probe common drug as clue to mysterious liver disease
NCT ID NCT05912387
Summary
This study aims to understand why patients develop a serious liver disease called Primary Sclerosing Cholangitis (PSC), which has no cure and often leads to cancer or transplant. Researchers will give 15 adult patients with PSC a common cholesterol-lowering drug (rosuvastatin) to see how it changes their gut bacteria and bile acids. The goal is to gather basic biological clues that could help guide future drug development, not to treat the disease directly.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY SCLEROSING CHOLANGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University
RECRUITINGStanford, California, 94305, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.